Mark Chin - Insider Trading & Ownership

Entity
Individual
Location
20 Berkeley Square, Mayfair, London, United Kingdom
Summary
The estimated net worth of Mark Chin is at least $35.5M dollars as of June 14, 2024. Mark Chin is the Director of IMARA Inc. and owns shares of Enliven Therapeutics, Inc. (ELVN) stock worth about $35.5M. Mark Chin is the Director of Iterum Therapeutics plc and owns shares of Iterum Therapeutics plc (ITRM) stock worth about $25.6K.
All Insider Reports
All Insider Reports

Ownership of Mark Chin

Insider Transactions Reported by Mark Chin:

* An asterisk sign (*) next to the price indicates that the price is likely invalid.